Baker Avenue Asset Management, LP Novo Nordisk A S Transaction History

Baker Avenue Asset Management, LP

  • $3.41 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $173,587 - $231,063
1,700 New
1,700 $218,000
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $33,556 - $73,630
369 Added 100.0%
738 $67,000
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $6,395 - $7,078
-41 Reduced 10.0%
369 $59,000
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $5,425 - $6,524
41 Added 11.11%
410 $65,000
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $37,840 - $49,936
369 New
369 $49,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email